Thrombotic microangiopathies: a general approach to diagnosis and management.

about

Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.

P2860

Q47093315-793CD619-A925-482B-B1F3-C61A6E95B917

P2860

Thrombotic microangiopathies: a general approach to diagnosis and management.

Item

http://www.wikidata.org/entity/Q38984066

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Thrombotic microangiopathies: a general approach to diagnosis and management.

@en

type

Item

label

Thrombotic microangiopathies: a general approach to diagnosis and management.

@en

prefLabel

Thrombotic microangiopathies: a general approach to diagnosis and management.

@en

P1476

Thrombotic microangiopathies: a general approach to diagnosis and management.

@en

P2093

Christopher J Patriquin

http://www.w3.org/2001/XMLSchema#string

Donald M Arnold

http://www.w3.org/2001/XMLSchema#string

Ishac Nazy

http://www.w3.org/2001/XMLSchema#string

P2860

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Morphologic diagnosis of thrombotic thrombocytopenic purpura.

von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.

P304

E153-E159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.160142

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27754896

http://www.w3.org/2001/XMLSchema#string

P932

5266569

http://www.w3.org/2001/XMLSchema#string

Thrombotic microangiopathies: a general approach to diagnosis and management.

about

P2860

P2860

Thrombotic microangiopathies: a general approach to diagnosis and management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932